Advisornet Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $771K | Buy |
32,018
+793
| +3% | +$20.7K | 0.04% | 328 |
|
|
2026
Q1 | $877K | Sell |
31,225
-6,610
| -17% | -$176K | 0.05% | 280 |
|
|
2025
Q4 | $942K | Buy |
37,835
+2,182
| +6% | +$55K | 0.05% | 265 |
|
|
2025
Q3 | $908K | Sell |
35,653
-6,762
| -16% | -$167K | 0.05% | 268 |
|
|
2025
Q2 | $1.03M | Sell |
42,415
-4,197
| -9% | -$97.9K | 0.07% | 243 |
|
|
2025
Q1 | $1.18M | Buy |
46,612
+3,341
| +8% | +$87.4K | 0.09% | 217 |
|
|
2024
Q4 | $1.15M | Sell |
43,271
-2,005
| -4% | -$54.4K | 0.1% | 194 |
|
|
2024
Q3 | $1.31M | Sell |
45,276
-886
| -2% | -$25.8K | 0.1% | 197 |
|
|
2024
Q2 | $1.29M | Sell |
46,162
-10,670
| -19% | -$294K | 0.12% | 178 |
|
|
2024
Q1 | $1.58M | Sell |
56,832
-1,390
| -2% | -$38.6K | 0.15% | 149 |
|
|
2023
Q4 | $1.68M | Sell |
58,222
-4,176
| -7% | -$126K | 0.15% | 154 |
|
|
2023
Q3 | $2.07M | Sell |
62,398
-7,220
| -10% | -$255K | 0.19% | 117 |
|
|
2023
Q2 | $2.55M | Sell |
69,618
-407
| -0.6% | -$15.8K | 0.22% | 111 |
|
|
2023
Q1 | $2.86M | Buy |
70,025
+24
| +0% | +$1.04K | 0.26% | 94 |
|
|
2022
Q4 | $3.59M | Sell |
70,001
-3,271
| -4% | -$157K | 0.35% | 72 |
|
|
2022
Q3 | $3.21M | Buy |
73,272
+63
| +0.1% | +$3.06K | 0.32% | 78 |
|
|
2022
Q2 | $3.84M | Sell |
73,209
-3,140
| -4% | -$160K | 0.38% | 67 |
|
|
2022
Q1 | $3.95M | Buy |
76,349
+13,158
| +21% | +$683K | 0.25% | 98 |
|
|
2021
Q4 | $3.73M | Sell |
63,191
-241
| -0.4% | -$11.9K | 0.23% | 104 |
|
|
2021
Q3 | $2.73M | Sell |
63,432
-18,316
| -22% | -$811K | 0.19% | 109 |
|
|
2021
Q2 | $3.2M | Buy |
81,748
+169
| +0.2% | +$6.57K | 0.21% | 112 |
|
|
2021
Q1 | $2.96M | Sell |
81,579
-20,480
| -20% | -$727K | 0.21% | 107 |
|
|
2020
Q4 | $3.76M | Buy |
102,059
+18,581
| +22% | +$682K | 0.3% | 73 |
|
|
2020
Q3 | $2.91M | Buy |
83,478
+24,896
| +42% | +$873K | 0.25% | 94 |
|
|
2020
Q2 | $1.82M | Sell |
58,582
-71
| -0.1% | -$2.41K | 0.15% | 144 |
|
|
2020
Q1 | $1.82M | Sell |
58,653
-8,739
| -13% | -$298K | 0.17% | 124 |
|
|
2019
Q4 | $2.5M | Sell |
67,392
-16,969
| -20% | -$604K | 0.21% | 105 |
|
|
2019
Q3 | $2.88M | Buy |
84,361
+17,357
| +26% | +$631K | 0.26% | 86 |
|
|
2019
Q2 | $2.75M | Buy |
67,004
+7,183
| +12% | +$285K | 0.3% | 74 |
|
|
2019
Q1 | $2.41M | Buy |
59,821
+2,376
| +4% | +$95.2K | 0.29% | 79 |
|
|
2018
Q4 | $2.38M | Buy |
57,445
+1,299
| +2% | +$53.9K | 0.33% | 67 |
|
|
2018
Q3 | $2.35M | Buy |
56,146
+5,601
| +11% | +$216K | 0.3% | 68 |
|
|
2018
Q2 | $1.74M | Sell |
50,545
-3,000
| -6% | -$103K | 0.24% | 89 |
|
|
2018
Q1 | $1.8M | Buy |
53,545
+17,929
| +50% | +$616K | 0.25% | 83 |
|
|
2017
Q4 | $1.22M | Buy |
+35,616
| New | +$1.21M | 0.19% | 108 |
|
Other funds holding PFE
Advisornet Financial's PFE Position: Q2 2026 in Review
Advisornet Financial increased its Pfizer (PFE) stake by 2.5% in Q2 2026, buying an estimated $20.7K and bringing the position to 32,018 shares worth $771K. The position accounts for 0.04% of the portfolio, ranked #328.
Advisornet Financial first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $3.95M in Q1 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Advisornet Financial held 32,018 shares of Pfizer worth $771K as of Q2 2026.
- Advisornet Financial bought 793 Pfizer shares in Q2 2026, an estimated $20.7K.
- Pfizer made up 0.04% of Advisornet Financial's portfolio in Q2 2026, its #328 holding.
- Advisornet Financial first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- Advisornet Financial's Pfizer position peaked at $3.95M in Q1 2022.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.